BioSpace News Archive

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced it will release its second quarter 2020 financial results after the market closes on Thursday, August 6, 2020. In conjunction with the release, the Company will host a conference call and webcast that day at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time to discuss its financial results and recent highlights. Interested pa

ENDRA Life Sciences Inc., a pioneer of Thermo Acoustic Enhanced UltraSound is mourning the loss of Sanjiv “Sam” Gambhir, M.D, Ph.D, a member of ENDRA’s Board of Directors, who passed away July 18, 2020.

The Menarini Group and Radius Health, Inc. (Nasdaq: RDUS) announced today that the companies have entered into an exclusive global license agreement for development and commercialization of elacestrant.

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) announced today that the company submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for vosoritide, an investigational, once daily injection analog of C-type Natriuretic Peptide (CNP) for children with achondroplasia,

eHealth, Inc. (NASDAQ: EHTH), a leading private online health insurance marketplace, announces today its financial results for the second quarter ended June 30, 2020.

Vilex, LLC, a member of the Squadron Capital family of businesses, announced today that it has successfully completed the acquisition of DT MedTech, LLC, whose product lines include the Hintermann Series System™ Total Ankle Replacement (TAR), developed by prominent surgeon, Professor Beat Hintermann.

Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $1.60 per share dividend for the third quarter of 2020. The dividend will be paid on September 8, 2020 , to all stockholders of record as of the close of business on August 17, 2020 . About Amgen Amgen is committed to unlocking the potential

Edwards Lifesciences Corporation, the global leader in patient-focused innovations for structural heart disease and critical care monitoring, reported financial results for the quarter ended June 30, 2020.

Jamieson Wellness Inc. (“Jamieson Wellness” or the “Company”) (TSX:JWEL) announced today that the Company will release its second quarter 2020 financial results after the market close on Wednesday, August 12, 2020. The Company will host a conference call for investors at 5:00 p.m. Eastern Time to discuss the second quarter 2020 results. The call can be accessed live over the telephone by dialing 1-800-437-2398 from Canada a

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced it will host its second quarter 2020 investor update conference call and webcast at 8:30 a.m. Eastern Time on Thursday, August 6, 2020. Individuals interested in participating in the call should dial (866) 324-3683 (U.S. and Canada) or (509) 844-0959 (international) using conference ID number and event passcode 6183913. To access the webcast, please visit the Investo